logo
TRANSPLANTATION OF ORGANS FROM MARGINAL DONORS1
Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation 2001; 72: 1432.
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation 2001; 72: 1399.
REGULATION OF GLUTATHIONE REDOX STATUS IN LUNG AND LIVER BY CONDITIONING REGIMENS AND KERATINOCYTE GROWTH FACTOR IN MURINE ALLOGENEIC BONE MARROW TRANSPLANTATION1
SHORT-TERM “PRECONDITIONING” WITH INHALED NITRIC OXIDE PROTECTS RABBIT LUNGS AGAINST ISCHEMIA-REPERFUSION INJURY1
ADVANCED GLYCATION END PRODUCT LEVELS IN EYE LENSES, AORTA, AND TAIL TENDON IN TRANSPLANTED DIABETIC INBRED LEWIS RATS1
USE OF MARGINAL ORGANS FROM NON-HEART-BEATING CADAVERIC KIDNEY DONORS
PREOPERATIVE ANTIVIRAL TREATMENT AND POSTOPERATIVE PROPHYLAXIS IN HBV-DNA POSITIVE PATIENTS UNDERGOING LIVER TRANSPLANTATION
VASCULAR ENDOTHELIAL FUNCTION IN CYCLOSPORINE AND TACROLIMUS TREATED RENAL TRANSPLANT RECIPIENTS1,2
SUPRAHEPATIC VENACAVAPLASTY (CAVAPLASTY) WITH RETROHEPATIC CAVA EXTENSION IN LIVER TRANSPLANTATION: EXPERIENCE WITH FIRST 115 CASES
CYTOMEGALOVIRUS DISEASE IS NOT A MAJOR RISK FACTOR FOR ISCHEMIC HEART DISEASE AFTER RENAL TRANSPLANTATION1
COMPLETE REGRESSION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE USING PARTIALLY HLA-MATCHED EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS1
INCREASED WEAKNESS AFTER PANCREAS AND KIDNEY TRANSPLANTATION1
ALLOCHIMERIC CLASS I MHC MOLECULES PREVENT CHRONIC REJECTION AND ATTENUATE ALLOANTIBODY RESPONSES1
ALTERATIONS IN TRANSCRIPTION FACTOR BINDING AT THE IL-2 PROMOTER REGION IN ANERGIZED HUMAN CD4+ T LYMPHOCYTES
COSTIMULATION BLOCKADE PROMOTES THE APOPTOTIC DEATH OF GRAFT-INFILTRATING T CELLS AND PROLONGS SURVIVAL OF HEPATIC ALLOGRAFTS FROM FLT3L-TREATED DONORS1
IMMUNOMODULATION BY INTRATHYMIC INJECTION OF DONOR LEUKOCYTES IN RHESUS MONKEYS1
PROTEASE-ACTIVATED RECEPTOR 1 AND PLASMINOGEN ACTIVATOR INHIBITOR 1 EXPRESSION IN CHRONIC ALLOGRAFT NEPHROPATHY
ASSOCIATION OF CYTOKINE POLYMORPHIC INHERITANCE AND IN VITRO CYTOKINE PRODUCTION IN ANTI-CD3/CD28-STIMULATED PERIPHERAL BLOOD LYMPHOCYTES1
TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE USING BETAMETHASONE ENEMAS
THE URINE PROTEIN TO CREATININE RATIO (P/C) AS A PREDICTOR OF 24-HOUR URINE PROTEIN EXCRETION IN RENAL TRANSPLANT PATIENTS
FACTOR XIII REPLACEMENT IN STEM CELL TRANSPLANT (SCT) RECIPIENTS WITH SEVERE GRAFT-VERSUS-HOST DISEASE OF THE BOWEL: REPORT OF AN INITIAL EXPERIENCE
INTERAORTOCAVAL RENAL ARTERY DISSECTION FOR RIGHT LAPAROSCOPIC DONOR NEPHRECTOMY
RESPIRATORY VIRUS INFECTIONS IN ADULT T CELL-DEPLETED TRANSPLANT RECIPIENTS: THE ROLE OF CELLULAR IMMUNITY
PROVOCATIVE EFFECTS OF THE IMMUNOSUPPRESSANTS RAPAMYCIN, TACROLIMUS, AND DEXAMETHASONE ON Pneumocystis carinii PNEUMONITIS IN CONTRAST TO THE ANTI-Pneumocystis carinii PNEUMONITIS EFFECTS OF MYCOPHENOLATE MOFETIL
PROVOCATIVE EFFECTS OF THE IMMUNOSUPPRESSANTS RAPAMYCIN, TACROLIMUS, AND DEXAMETHASONE ON Pneumocystis carinii PNEUMONITIS IN CONTRAST TO THE ANTI-Pneumocystis carinii PNEUMONITIS EFFECTS OF MYCOPHENOLATE MOFETIL
LOW ABSOLUTE GLOMERULAR FILTRATION RATES IN THE LIVING KIDNEY DONOR: A RISK FACTOR FOR GRAFT LOSS
RECOMMENDATIONS OF THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE HEART AND LUNG TOLERANCE WORKING GROUP
ANNOUNCEMENTS